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ABSTRACT 
 
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, 
but credible estimates from the World Health Organization and the International Agency for 
Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic 
environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose 
exposures to mixtures of chemicals in the environment may be combining to contribute to 
environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple 
priority target sites for disruption in each area and prototypical chemical disruptors for all 
targets, this included dose-response characterizations, evidence of low-dose effects and cross-
hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were 
reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% 
(13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) 
exerted low-dose effects. No dose-response information was found for the remaining 26% 
(22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) 
chemicals acting on different pathways, and a variety of related systems, organs, tissues and 
cells could plausibly conspire to produce carcinogenic synergies. Additional basic research 
on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be 
rigorously pursued before the merits of this hypothesis can be further advanced. However, the 
structure of the World Health Organization International Programme on Chemical Safety 
‘Mode of Action’ framework should be revisited as it has inherent weaknesses that are not 
fully aligned with our current understanding of cancer biology. 
 
